ReviewFrontiers in immunology2025

Sepsis-driven metabolic reprogramming shapes cancer immunotherapy efficacy, metastatic potential, and drug sensitivity.

Leyi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.